SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-16-133512
Filing Date
2016-07-20
Accepted
2016-07-20 16:01:16
Documents
48
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a16-11521_110q.htm 10-Q 643106
2 EX-31.1 a16-11521_1ex31d1.htm EX-31.1 11045
3 EX-31.2 a16-11521_1ex31d2.htm EX-31.2 11713
4 EX-32.1 a16-11521_1ex32d1.htm EX-32.1 7995
  Complete submission text file 0001104659-16-133512.txt   3477985

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT snta-20160630.xml EX-101.INS 729269
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT snta-20160630.xsd EX-101.SCH 30208
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT snta-20160630_cal.xml EX-101.CAL 32219
8 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT snta-20160630_lab.xml EX-101.LAB 311038
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT snta-20160630_pre.xml EX-101.PRE 214242
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT snta-20160630_def.xml EX-101.DEF 111354
Mailing Address
Business Address 45 HARTWELL AVE LEXINGTON MA 02421 781-274-8200
SYNTA PHARMACEUTICALS CORP (Filer) CIK: 0001157601 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33277 | Film No.: 161775455
SIC: 2834 Pharmaceutical Preparations